PitchSend

Investor Presentaiton

Growth Strategies and Plans 3 JUBILANT LIFESCIENCES 5 4 Develop a diverse product and service portfolio through differentiated and complex offerings ➤ Specialty Pharmaceuticals Focus: Develop differentiated products in the radiopharmaceuticals and specialty injectables segments catering to the North American market CDMO Focus: Focus on driving growth through capacity expansion in CMO business and new filings in the API business Generics Focus: Focus on developing complex products with limited competition and to file products that can be integrated with our in-house API manufacturing Life Science Chemicals Focus: Expand to new chemistry platform of Diketene, Capacity enhancement of Acetic Anhydride and expand customer base in global markets ➤ Specialty Intermediates Focus: Focus on developing new products using existing assets, Expand customer base for CDMO and establish agro active business Nutritional Products Focus - Productivity & Profitability improvement, Expansion into new segments like encapsulated products and develop food ingredients portfolio Offer an integrated business model that provides products and services which are cost-effective Cost Competitive API Manufacturing: Continue to increase share of solid dosage formulations manufactured with in-house APIs Vertical Integration: Leverage network of radiopharmacies to distribute radiopharmaceutical products Operational Efficiency: Leveraging capabilities across an expanded revenue base thereby gaining scale in operations Cost Competitive Manufacturing in LSI: Continue to increase share of chemicals manufactured Leverage vertical Integration in LSI: Leverage integration from basic feed-stock to drive growth Operational Efficiency in LSI: Leveraging capabilities across an expanded revenue base thereby gaining scale in operations Continue to pursue strategic acquisitions to further consolidate leadership positions and accelerate growth Potential Future Acquisition Areas: Radiopharmacy sales and distribution network in the US and Canada Manufacturing capacity and capabilities to further strengthen the radiopharmaceutical portfolio focused on the North American market Manufacturing sites in India to support Dosage and API businesses JUBILANT LIFESCIENCES

View entire presentation